Institute of Biomedicine
1 of 31
460 of 523
- Takykiniinireseptorin antagonistit (2024)
- Takykiniinireseptorin antagonistit (2019)
- Targeted destruction of follicle stimulating hormone receptor-positive cancer cells in vitro and in vivo by a lytic peptide Phor21-FSHβ conjugate (2025)
- Targeted modulation of cell differentiation in distinct regions of the gastrointestinal tract via oral administration of differently PEG-PEI functionalized mesoporous silica nanoparticles (2016)
- Targeted serum proteomics of longitudinal samples from newly diagnosed youth with type 1 diabetes affirms markers of disease (2025)
- Targeted therapies don't work for a reason; the neglected tumor suppressor phosphatase PP2A strikes back (2018)
- Targeting CD39 with a first-in-class inhibitory antibody prevents ATP processing and increases T-cell activation (2019)
- Targeting DNA Homologous Repair Proficiency With Concomitant Topoisomerase II and c-Abl Inhibition (2021)
- Targeting Hyaluronan in Vascular Diseases with Special Reference to Diabetic Macroangiopathy (2019)
- Targeting of vascular adhesion protein-1 by positron emission tomography visualizes sites of inflammation in Borrelia burgdorferi-infected mice (2017)
UTU Research Portal